N/A 4. DELIVERABLES: N/A 5. EVIDENCE : N/A 6. RECOMMENDATION/ACTION REQUIRED: The <strong>Trust</strong> <strong>Board</strong> is request to approve the report <strong>and</strong> note the actions to mitigate risk in achieving the control total deficit of £39.7m AGREED AT ______________________ MEETING, OR REFERRED TO: ______________________ DATE: ____________________________ DATE: ____________________________ REVIEW DATE _________________________ (if applicable) 2
1. EXECUTIVE SUMMARY Monthly I&E Run rate m £ 43.0 41.0 39.0 37.0 35.0 33.0 31.0 29.0 Month 6 ‐ Monthly Run Rate Trend 1 2 3 4 5 6 7 8 9 10 11 12 Incom e Exp net of Blue/Green/Amber CIP Expenditure Further red CIPs required to m eet forecast <strong>Trust</strong> I&E Summary (+ve variances = favourable, -ve = adverse) <strong>2012</strong>/13 In Month (£'000) <strong>2012</strong>/13 Year to date (£'000) <strong>2012</strong>/13 <strong>2012</strong>/13 Foreast (£'000) 2011/12 2011/12 YTD Annual Actual £'000 Var £'000 Var % Actual £'000 Var £'000 Var % Actual £'000 Budget £'000 Actual £'000 Var £'000 Var % Actual (35,508) 1,296 3.79% Income (209,703) 2,138 1.03% (198,584) (413,055) (420,630) 7,575 -1.83% (419,121) Expenditure 24,509 (159) -0.65% - Pay 147,555 (571) -0.39% 144,367 292,971 297,334 (4,363) -1.49% 291,010 11,068 (207) -1.90% - Non-pay 67,348 (527) -0.79% 66,700 132,269 133,954 (1,685) -1.27% 138,248 (656) -100.00% - QIPP/Cost Reduction (2,782) (13,710) (8,446) (5,264) 38.40% (78) -100.00% - Contract adjmt. & reserves (189) (122) 3,088 (3,210) 2635.09% 68 198 74.33% EBITDA 5,200 (1,931) -59.07% 12,482 (1,646) 5,300 (6,946) 10,137 ITDA 1,171 37 3.08% - Depreciation 7,104 143 1.97% 7,003 14,494 14,162 332 2.29% 14,033 355 0.00% - Capital Dividends 2,132 0.00% 1,943 4,263 4,263 0.00% 3,613 1,823 21 1.11% - Net Interest 11,904 22 0.19% 11,488 23,822 23,756 66 0.28% 23,011 3,417 255 6.95% Net position 26,339 (1,766) -7.18% 32,917 40,933 47,481 (6,548) -16.00% 50,794 Impairments (2,005) (5,318) (2,005) (2,005) (1,133) 3,417 255 6.95% Net position 24,334 (1,766) -7.82% 27,599 38,928 45,476 (6,548) -16.82% 49,661 In Month <strong>and</strong> YTD Performance Income • Income of £35.5m in Month Six was £1.3m over the plan <strong>and</strong> is £2.1m ahead of plan YTD. The ONEL contract is £4.8m ahead of contract YTD, less transitional funding not agreed of £2.1m, with a forecast over-performance of £13.0m, less £4.3m transitional funding. Over-performance has continued to increase, particularly for non-elective activity, which is only funded at 30% marginal tariff above 2011/12 baseline, against which the commissioners are applying a 65% marginal tariff (i.e. net 20% tariff). The forecast expenditure position now includes £1.8m of non-elective costs not covered by the marginal tariff. Pay expenditure • Pay is £159k overspent in the Month, mainly related to Medical staffing £129k (Radiology £71k <strong>and</strong> Specialist Surgery £93k) <strong>and</strong> £78k (Acute Medicine £128k). • The YTD position is £571k overspent, mainly related to Medical staff £508k (Radiology £497k) <strong>and</strong> Nursing staff £595k (mainly Acute Medicine £640k <strong>and</strong> Midwifery £243k, partly offset by under spending in Corporate Nursing budgets), both partly offset by under spending on Management/Admin staff of £679k. Non-pay expenditure • Non-pay is £207k overspent in the Month, mainly related to Pathology £109k <strong>and</strong> Pharmacy £136k • YTD the overspending is £527k, mainly related to Pathology £355k <strong>and</strong> Specialist Medicine (£224k – Oncology <strong>and</strong> Pharmacy) EBITDA • Earnings before Interest, Tax, Depreciation <strong>and</strong> amortisation (EBITDA) were £0.1m negative in the Month <strong>and</strong> £5.2m negative YTD. The improved in month position was primarily driven by income. The YTD EBITDA of £5.2m negative is £1.9m adverse against plan YTD but has improved by £7.3m compared with the same period last year. The forecast is £5.3m negative, £4.8m better than last year’s outturn.. Net deficit • The net deficit is £25.7m to date, which is £1.8m worse than plan. The forecast deficit is £46.8m, primarily related to: o £4.3m transitional income support not agreed by commissioners o £1.0m increased income over-performance not agreed by commissioners o £1.8m unfunded cost of Non-elective activity • The forecast assumes full delivery of £4.8m red-rated CIPs (in addition to the £12.9m CIP rated as blue/green/amber, making a total of £17.7m) Add back - Impairment 2,005 2,005 2,005 1,133 121 (221) IFRS reversed (380) (221) (1,202) (759) (443) (882) 3,538 34 Net against control 25,960 (1,987) 39,731 46,722 (6,991) 49,912 3
- Page 1 and 2:
TRUST BOARD MEETING Wednesday, 7 No
- Page 3 and 4:
2 Following Mr White’s concerns r
- Page 5 and 6:
4 forecast in terms of community be
- Page 7 and 8:
6 The Trust Board noted the Plan fo
- Page 9 and 10:
8 The Co-Chair of the Improving Pat
- Page 11 and 12:
TRUST BOARD MEETING Actions from Mi
- Page 13 and 14:
Agenda Item Action Deadline Date Da
- Page 15 and 16:
Question: Mr Skillman was pleased t
- Page 17 and 18:
CQC Trust-wide Action Plan Review a
- Page 19 and 20:
1.0 PURPOSE 1.1 Background This rep
- Page 21 and 22:
• Review the Senior Responsible O
- Page 23 and 24:
APPENDIX 1 ‐ CQC ACTION PLAN - EX
- Page 25 and 26:
RECORDS records management to ensur
- Page 27 and 28:
CQC Update Report 2012 Theme CQC Re
- Page 29 and 30:
CQC Update Report 2012 ASSESSING &
- Page 31 and 32:
CQC Update Report 2012 ASSESSING &
- Page 33 and 34:
CQC Update Report 2012 pathways thr
- Page 35 and 36:
CQC Update Report 2012 identified i
- Page 37 and 38:
CQC Update Report 2012 outlining th
- Page 39 and 40:
CQC Update Report 2012 improvements
- Page 41 and 42:
CQC Update Report 2012 aware of the
- Page 43 and 44:
CQC Update Report 2012 are now supe
- Page 45 and 46:
CQC Update Report 2012 autumn. RECO
- Page 47 and 48:
CQC Update Report 2012 of the pilot
- Page 49 and 50:
EXECUTIVE SUMMARY TITLE: Informatio
- Page 51 and 52:
INFORMATION GOVERNANCE STRATEGY 201
- Page 53 and 54:
Information is a vital asset in ter
- Page 55 and 56:
starters as well as being mandatory
- Page 57 and 58:
The standards are split into the ar
- Page 59 and 60:
10a Reapproval of IG training progr
- Page 61 and 62:
343 Directorate Anaesthetic: Risk:
- Page 63 and 64:
Table of Contents TRUST PRINCIPAL O
- Page 65 and 66:
BHRUT STRATEGIC OBJECTIVES WITH EAC
- Page 67 and 68:
DIRECTORATES RISKS REVIEW 12 10 8 6
- Page 69 and 70:
RISKS DETAILS PRINCIPAL RISK What c
- Page 71 and 72:
PRINCIPAL RISK What could prevent t
- Page 73 and 74:
PRINCIPAL RISK What could prevent t
- Page 75 and 76:
PRINCIPAL RISK What could prevent t
- Page 77 and 78:
RISK DESCRIPTORS OBJECTIVE SAFE, HI
- Page 79 and 80:
BOARD ASSURANCE FRAMEWORK ELEMENTS
- Page 81 and 82:
EXECUTIVE SUMMARY TITLE: Risk Manag
- Page 83 and 84:
Contents Section Page 1 Introductio
- Page 85 and 86:
incorporate mitigation controls wit
- Page 87 and 88:
“Risk Register” “Risk Registe
- Page 89 and 90:
potential risks they may face in ac
- Page 91 and 92:
4.1.1 Quality and Safety Committee
- Page 93 and 94:
• Financial risks: risks associat
- Page 95 and 96:
Proactive risk assessment enables t
- Page 97 and 98:
Trust’s risk matrix and will popu
- Page 99 and 100:
Risk Grading Staff Group Evidence R
- Page 101 and 102:
4.8 RISK REGISTER The Risk Register
- Page 103 and 104:
5.1 Consultation and Communication
- Page 105 and 106:
The Trust recognises the importance
- Page 107 and 108:
timescale with supporting evidence
- Page 109 and 110:
Checklist for the Review and Approv
- Page 111 and 112:
Equality Impact Assessment Tool To
- Page 113 and 114:
Plan for Dissemination of Procedura
- Page 115 and 116:
Consequence score (severity levels)
- Page 117 and 118:
Frequency How often might it/does i
- Page 119 and 120:
Appendix 3 Framework for Risk Manag
- Page 121 and 122:
Risk Register inventory they are ex
- Page 123 and 124:
2. DECISION REQUIRED: CATEGORY: The
- Page 125 and 126:
• A review of data capture to ens
- Page 127 and 128:
Pilot Wards Division Discharges Per
- Page 129 and 130:
Workforce Appraisals - the actions
- Page 131 and 132:
Delayed transfers of care (DTOC) -
- Page 133 and 134:
EXECUTIVE SUMMARY TITLE: Emergency
- Page 135 and 136:
• Training competencies are being
- Page 137 and 138:
Appendix A: Trajectory for all type
- Page 139 and 140:
would welcome feedback from the Tru
- Page 141 and 142:
Maternity Services Monthly Performa
- Page 143 and 144:
4. Capping The maternity service is
- Page 145 and 146:
7. Obstetric Assessment Unit (OAU)
- Page 147 and 148:
10. Serious Incidents Reported Inci
- Page 149 and 150:
12. Maternity Dashboard The dashboa
- Page 151 and 152:
It should also be noted that the ta
- Page 153 and 154:
Priority Action Lead Monitoring Too
- Page 155 and 156:
Priority Action Lead Monitoring Too
- Page 157 and 158:
Contents Section No: Description Pa
- Page 159 and 160:
3. Complaints Activity 3.1 Total Co
- Page 161 and 162:
3.5 Themes General care issues and
- Page 163 and 164:
Corporate Non Clinical Category Num
- Page 165 and 166:
order to resolve concerns. Particul
- Page 167 and 168:
The findings of the review were tha
- Page 169 and 170:
SELF-CERTIFICATION RETURNS Organisa
- Page 171 and 172:
12 AA - Quality Improvement Strateg
- Page 173 and 174:
TFA Progress BHR University Hospita
- Page 175 and 176: 25 TFA - Final IBP /; LTFM Dec-12 H
- Page 177 and 178: Effectiveness GOVERNANCE RISK RATIN
- Page 179 and 180: Safety 4b MRSA Enter Are you below
- Page 181 and 182: FINANCIAL RISK RATING BHR Universit
- Page 183 and 184: CONTRACTUAL DATA BHR University Hos
- Page 185 and 186: 4 Single Sex Accommodation Breaches
- Page 187 and 188: TITLE: EXECUTIVE SUMMARY BOARD/GROU
- Page 189 and 190: causes/ Not specified' will be remo
- Page 191 and 192: Staff In Post Starters & Leavers FT
- Page 193 and 194: TURNOVER Actual Versus Target Annua
- Page 195 and 196: FTE Lost due to Sickness Absence by
- Page 197 and 198: The data on the previous page has b
- Page 199 and 200: Indicator Target Apr-12 May-12 Jun-
- Page 201 and 202: Starters *¹ 7.00 3.60 5.00 7.43 6.
- Page 203 and 204: EXECUTIVE SUMMARY TITLE: COST IMPRO
- Page 205 and 206: Month 6 CIP Performance Workstream
- Page 207 and 208: Governance The Cost Improvement Pro
- Page 209 and 210: 1 REPORT TO: REPORT FROM: Trust Boa
- Page 211 and 212: 3 Preparations for winter planning
- Page 213 and 214: 5 Preparing the Payment by Results
- Page 215 and 216: 7 People with dementia to receive m
- Page 217 and 218: 9 Clinical Patient Management and H
- Page 219 and 220: 102/2012 Apologies Apologies were r
- Page 221 and 222: Action Members were advised that ac
- Page 223 and 224: Action 115/2012 Any Other Business
- Page 225: EXECUTIVE SUMMARY TITLE: Finance Re
- Page 229 and 230: Trust I&E summary by Division/Direc
- Page 231 and 232: Income by POD In Month Year to date
- Page 233 and 234: Devolved income Annual Budget Forec
- Page 237 and 238: 4. BALANCE SHEET Balance Sheet Curr
- Page 239: 6. Business Unit Summaries Attached